Equities Analysts Offer Predictions for Waters Co.’s Q4 2024 Earnings (NYSE:WAT)

Waters Co. (NYSE:WATFree Report) – Research analysts at Zacks Research increased their Q4 2024 earnings estimates for shares of Waters in a note issued to investors on Tuesday, May 28th. Zacks Research analyst S. Mete now expects that the medical instruments supplier will earn $4.13 per share for the quarter, up from their prior estimate of $4.07. The consensus estimate for Waters’ current full-year earnings is $11.86 per share. Zacks Research also issued estimates for Waters’ Q3 2025 earnings at $3.44 EPS, Q4 2025 earnings at $4.27 EPS, FY2025 earnings at $12.79 EPS, Q1 2026 earnings at $2.69 EPS and FY2026 earnings at $14.32 EPS.

A number of other research analysts have also recently weighed in on the stock. Stifel Nicolaus boosted their target price on shares of Waters from $330.00 to $332.00 and gave the company a “hold” rating in a research note on Wednesday, May 8th. TD Cowen upped their price target on shares of Waters from $350.00 to $358.00 and gave the company a “hold” rating in a research note on Wednesday, May 8th. Evercore ISI upped their price target on shares of Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. Robert W. Baird dropped their price target on shares of Waters from $319.00 to $312.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 8th. Finally, Barclays dropped their price target on shares of Waters from $300.00 to $295.00 and set an “underweight” rating on the stock in a research note on Wednesday, May 8th. One analyst has rated the stock with a sell rating and ten have given a hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $305.78.

Read Our Latest Report on Waters

Waters Stock Down 6.2 %

WAT opened at $307.45 on Thursday. The company has a quick ratio of 1.30, a current ratio of 1.94 and a debt-to-equity ratio of 1.60. The stock has a market cap of $18.24 billion, a price-to-earnings ratio of 30.17, a PEG ratio of 5.28 and a beta of 0.98. Waters has a twelve month low of $231.90 and a twelve month high of $367.21. The company’s 50-day moving average price is $331.21 and its two-hundred day moving average price is $320.97.

Waters (NYSE:WATGet Free Report) last released its earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share for the quarter, beating analysts’ consensus estimates of $2.10 by $0.11. The firm had revenue of $636.80 million for the quarter, compared to analysts’ expectations of $635.57 million. Waters had a net margin of 20.75% and a return on equity of 66.59%. The company’s quarterly revenue was down 7.0% on a year-over-year basis. During the same period in the previous year, the company earned $2.49 earnings per share.

Insiders Place Their Bets

In related news, Director Richard H. Fearon purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were purchased at an average price of $332.90 per share, with a total value of $332,900.00. Following the acquisition, the director now directly owns 1,653 shares of the company’s stock, valued at $550,283.70. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, Director Richard H. Fearon purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were purchased at an average price of $332.90 per share, with a total value of $332,900.00. Following the acquisition, the director now directly owns 1,653 shares of the company’s stock, valued at $550,283.70. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Linda Baddour sold 500 shares of the stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total transaction of $177,770.00. Following the transaction, the director now directly owns 2,250 shares in the company, valued at approximately $799,965. The disclosure for this sale can be found here. Corporate insiders own 0.82% of the company’s stock.

Hedge Funds Weigh In On Waters

Institutional investors and hedge funds have recently made changes to their positions in the business. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in shares of Waters by 9.7% during the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 55,889 shares of the medical instruments supplier’s stock valued at $15,325,000 after purchasing an additional 4,936 shares during the last quarter. Meridian Wealth Management LLC bought a new stake in Waters in the 4th quarter worth $2,637,000. Raymond James & Associates grew its holdings in Waters by 295.9% in the 4th quarter. Raymond James & Associates now owns 127,879 shares of the medical instruments supplier’s stock worth $42,102,000 after acquiring an additional 95,577 shares during the last quarter. Motley Fool Wealth Management LLC grew its holdings in Waters by 39.6% in the 4th quarter. Motley Fool Wealth Management LLC now owns 41,657 shares of the medical instruments supplier’s stock worth $13,728,000 after acquiring an additional 11,823 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in Waters by 3.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 357,257 shares of the medical instruments supplier’s stock worth $117,620,000 after acquiring an additional 13,093 shares during the last quarter. Institutional investors own 94.01% of the company’s stock.

Waters Company Profile

(Get Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.